All Articles

A new $43,000 federal investment aims to connect seniors and youth through reading, tackling isolation and strengthening French language roots in Ontario.

A new alliance between Made Scientific and Pluristyx promises to slash the time and cost of developing advanced iPSC therapies. But can it deliver on its promise?

Facing dire financial warnings, Cosmos Health plans to sell its own facilities to fund a comeback. Is it a stroke of genius or a desperate final gambit?

A blockbuster drug for chronic illness gets a generic rival, promising huge savings. But is it just about price? A deep dive into the strategy behind the new pill.

The 3rd annual National STEM Festival brings PhD-level student research to D.C., connecting young builders with leaders to solve real-world workforce shortages.

As Better Blend enters Tampa, its model reveals a new fast-casual paradigm where operational speed and personalized health aren't just perks—they're the core product.

A new executive hire at a cultural heritage firm signals a major shift. Can the architects of growth and the guardians of the past build the future together?

Ellucian's recent AI Excellence Award is more than a trophy. It signals a market shift to practical AI, but as the tech matures, are universities ready?

With millions set to lose Medicaid under new federal rules, Azara Healthcare’s acquisition of Advocatia creates a new tech arsenal for at-risk providers.

As J.B. Hunt executives prepare to address a key investor conference, all eyes are on their strategy for intermodal dominance and digital freight innovation.

Australian biotech Gelteq is opening a China R&D hub to chase explosive growth, but its bold move into a $60B market comes with significant geopolitical risks.

A new integration between Amplify's AI-native platform and Wealthbox CRM tackles operational drag, signaling a strategic shift toward a more connected future for RIAs.

Federal, provincial, and municipal governments unite in Sainte-Geneviève-de-Batiscan, turning a local landmark into a strategic asset for community care.

As Liberty Hill's population skyrockets, the arrival of a freestanding ER ends residents' long drives for urgent care, a milestone for the booming suburb.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.

A new AI suite for title production promises to cut processing time from days to hours, but its true innovation lies in keeping human experts in control.

Global software acquirer Vertus Group has landed in Mexico. Its 'forever-hold' strategy is set to reshape the M&A landscape for the nation's thriving tech scene.

For over five years, users have crowned Billtrust an AR automation leader. We dig into why this unbroken streak is more than a trophy—it’s a blueprint.

Scilex sets a date to pay out Semnur stock to its shareholders. We dig into whether this is a true value unlock or a move born from financial pressure.

As America rebuilds its industrial base, one firm is tearing down silos, offering a single-source solution of capital and real estate to power the economy.